[HTML][HTML] Recent progress on vascular endothelial growth factor receptor inhibitors with dual targeting capabilities for tumor therapy

Y Liu, Y Li, Y Wang, C Lin, D Zhang, J Chen… - Journal of Hematology & …, 2022 - Springer
Vascular endothelial growth factor receptors (VEGFRs) are a family of receptor protein
tyrosine kinases that play an important role in the regulation of tumor-induced angiogenesis …

Rational design of multitarget-directed ligands: strategies and emerging paradigms

J Zhou, X Jiang, S He, H Jiang, F Feng… - Journal of medicinal …, 2019 - ACS Publications
Due to the complexity of multifactorial diseases, single-target drugs do not always exhibit
satisfactory efficacy. Recently, increasing evidence indicates that simultaneous modulation …

[HTML][HTML] Hybrid drugs—a strategy for overcoming anticancer drug resistance?

M Szumilak, A Wiktorowska-Owczarek, A Stanczak - Molecules, 2021 - mdpi.com
Despite enormous progress in the treatment of many malignancies, the development of
cancer resistance is still an important reason for cancer chemotherapy failure. Increasing …

Recent progress on tubulin inhibitors with dual targeting capabilities for cancer therapy

W Shuai, G Wang, Y Zhang, F Bu, S Zhang… - Journal of Medicinal …, 2021 - ACS Publications
Microtubules play a crucial role in multiple cellular functions including mitosis, cell signaling,
and organelle trafficking, which makes the microtubule an important target for cancer …

Designing multi-targeted agents: An emerging anticancer drug discovery paradigm

R Fu, Y Sun, W Sheng, D Liao - European journal of medicinal chemistry, 2017 - Elsevier
The dominant paradigm in drug discovery is to design ligands with maximum selectivity to
act on individual drug targets. With the target-based approach, many new chemical entities …

Current advances of tubulin inhibitors as dual acting small molecules for cancer therapy

KE Arnst, S Banerjee, H Chen, S Deng… - Medicinal research …, 2019 - Wiley Online Library
Microtubule (MT)‐targeting agents are highly successful drugs as chemotherapeutic agents,
and this is attributed to their ability to target MT dynamics and interfere with critical cellular …

Blocking blood flow to solid tumors by destabilizing tubulin: an approach to targeting tumor growth

MJ Pérez-Pérez, EM Priego, O Bueno… - Journal of medicinal …, 2016 - ACS Publications
The unique characteristics of the tumor vasculature offer the possibility to selectively target
tumor growth and vascularization using tubulin-destabilizing agents. Evidence accumulated …

Development of dual inhibitors targeting epidermal growth factor receptor in cancer therapy

L Tan, J Zhang, Y Wang, X Wang, Y Wang… - Journal of Medicinal …, 2022 - ACS Publications
Epidermal growth factor receptor (EGFR) is of great significance in mediating cell signaling
transduction and tumor behaviors. Currently, third-generation inhibitors of EGFR, especially …

Design, Synthesis, and Herbicidal Activity of N-Benzyl-5-cyclopropyl-isoxazole-4-carboxamides

XL Sun, ZM Ji, SP Wei, ZQ Ji - Journal of Agricultural and Food …, 2020 - ACS Publications
Based on the structures of isoxaflutole (IFT) and N-isobutyl-N-(4-chloro-benzyl)-4-chloro-2-
pentenamide, a series of N-benzyl-5-cyclopropyl-isoxazole-4-carboxamides was designed …

Indole molecules as inhibitors of tubulin polymerization: potential new anticancer agents, an update (2013–2015)

R Patil, SA Patil, KD Beaman… - Future Medicinal Chemistry, 2016 - Taylor & Francis
Discovery of new indole-based tubulin polymerization inhibitors will continue to dominate
the synthetic efforts of many medicinal chemists working in the field. The indole ring system …